GLP-1 (28-36) amide (TFA)
GLP-1 (28-36) amide TFA, a C-terminal nonapeptide of GLP-1, is a major product derived from the cleavage of GLP-1 by the neutral endopeptidase (NEP) . GLP-1 (28-36) amide TFA is an antioxidant and targets to mitochondrion, inhibits mitochondrial permeability transition (MPT) . GLP-1 (28-36) amide TFA has anti-diabetic and cardioprotection effects[1].
Product Specifications
UNSPSC
12352209
Target
GCGR
Type
Peptides
Related Pathways
GPCR/G Protein
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/glp-1-28-36-amide-tfa.html
Solubility
10 mM in DMSO
Smiles
Molecular Formula
C56H86F3N15O11
Molecular Weight
1202.37
References & Citations
[1]Bilan Zhou, et al. GLP-1 (28-36) amide, a Long Ignored Peptide Revisited. Open Biochem J. 2014 Dec 31;8:107-11.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Glycophorin A / CD235a (Erythrocyte Marker) (GYPA/1725R), CF568 conjugate, 0.1mg/mL
GLUT-1 (Tumor Progression and Mesothelioma Marker) (GLUT1/2476), 1mg/mL
CD45RA (PTPRC/818), Biotin conjugate, 0.1mg/mL
Plakophilin 3 (PKP3) (C-term) Rabbit Polyclonal Antibody
